Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer With Tamoxifen.

NCT02197897 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02197897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02197897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer With Tamoxifen.
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Completed
Start date
April 1, 2015
Completion date
June 28, 2019
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer